Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Single-Dose, 5-Period Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Subjects With Narcolepsy Type 1
Conditions
Interventions
E2086
E2086 Placebo
+2 more
Locations
14
United States
SDS Clinical Trials
Santa Ana, California, United States
PharmaDev Clinical Research
Miami, Florida, United States
Sleep Practioners, LLC
Macon, Georgia, United States
Clinical Research Institute
Stockbridge, Georgia, United States
Sound Asleep Research, Inc.
Lansing, Michigan, United States
Research Carolina Elite
Denver, North Carolina, United States
Start Date
June 20, 2024
Primary Completion Date
March 17, 2025
Completion Date
March 17, 2025
Last Updated
June 4, 2025
Lead Sponsor
Eisai Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions